Abstract
Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken orally is limited by the relatively low solubility. Furosemide is a loop diuretic (a ‘water pill’) used to treat congestive heart failure, oedema and sometimes hypertension.
Method: The solid dispersion of Furosemide was prepared by Solvent evaporation method by using 1:1, 1:2 and 1:3 ratios of drug and polymers (PVP K-30, PEG6000). The solid dispersion was prepared by solvent evaporation method. The prepared solid dispersion was evaluated for various parameters like uniformity of drug content, in-vitro drug release and short term stability studies.
Results: The prepared dispersion showed marked increase in the dissolution rate of Furosemide than that of pure drug and the in vitro release studies revealed that there was an improvement in the dissolution characteristics of drug when prepared as solid dispersions. Solid dispersion with PEG 6000 and PVPK30 gave better rate and extent of dissolution.
Conclusion: It can be concluded that the solid dispersions prepared with PEG6000 and PVP K30 and among all the formulations, F6 has highest solubility and in vitro dissolution rate.
References
Yellela SRK, Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. Journal of Bioequivalence & Bioavailability2010; 2(2); 28–36.
Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 60: 1281e302. [View in PubMed]
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007; 12: 1068-1075. [View in PubMed]
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000; 50:47–60. [View in PubMed]
Serajuddin A. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999; 88: 1058-1066.
Sekiguchi K, Obi N. Studies on absorption of eutectic mixtures. I.A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem Pharm Bull. 1961; 9: 866–72.
Espinosa Bosch M, Ruiz Sánchez AJ, Sánchez Rojas F, Bosch Ojeda C. Recent developments in analytical determination of furosemide. J Pharm Biomed Anal 2008; 48:519-532. [View in PubMed]
Yamashita, K.; Nakate, T.; Okimoto, K.; Ohike, A.;et al Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J.
Pharm. 2003; : 79–91. [View in PubMed]
Chiou WL, Rigelman S. Pharmaceutical application of solid dispersion system. J Pharm Sci 1971; 60:1281-1302. [View in PubMed]
Van den Mooter, G.; Augustijns, P.; Blaton, et al Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol
and PVP K30. Int. J. Pharm. 1998, , 67–80.
Jahan ST, Khan MR, Moniruzzaman M, Rahman MR, Sadat M, Jalil RU. Enhancement of dissolution profile for oral delivery of fexofenadine hydrochloride by solid dispersion (solvent evaporation) technique. Am J Sci Ind Res 2011; 2: 112-115.
Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004; 272: 1-10. [View in PubMed]
Leuner C; Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000; 50:47-60. [View in PubMed]
S. Biswal, Enhancement of Dissolution Rate of Gliclazide using Solid Dispersions with Polyethylene Glycol 6000. AAPS Pharm Sci Tech. 2008; 9(2); 563–570. [View in PubMed]
Otra Kumar, Formulation and evaluation of solid dispersions of Flurbiprofen for dissolution rate enhancement. Journal of Chemical and Pharmaceutical Research2011; 3(6): 277-287.
Nair R, Gonen S, Hoag SW. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int J Pharm 2002; 240: 11–22. [View in PubMed]
Pai P.S. Effects of the eudragit and drug coat on the release behaviour of poorly soluble drug by solid dispersion technique IJPSR 2011; 2(4): 816-824.
M. Najmuddin enhancement in dissolution rate of ketoconazole by solid dispersion technique, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 2, Issue 3, 2010.
Meka AK, Pola S, Tupally KR, Abbaraju PL: Development, evaluation and characterization of surface solid dispersion for solubility and dissolution enhancement of Irbesartan. Int J Drug Dev Res 2012; 4(1): 263-273.
Okonogi S, Puttipipatkhachorn S. Dissolution improvement of high drug loaded solid dispersion. AAPS Pharm Sci Tech. 2006?7: E148–53. [View in PubMed]
Shah J, Vasanti S, Anroop B, Vyas H. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 and PEG 4000: Preparation and evaluation. J Incl Phenom Macrocycl Chem. 2009?63:69–75.
Patel RP, Patel DJ, Bhimani DB, Patel JK. Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinylpyrrolidone K30. Dissolut. Technol. 2008?15:17–25.
Patel RP, Patel MM. Physicochemical characterization and dissolution study of solid dispersions of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm Dev Tech. 2007?12:21–33.
De PK, Sahana B, Rakshit S. Enhancement of Dissolution rate and stability study of Ofloxacin Solid dispersion, Der Pharmacia Sinica, 2011, 2 (5):169-181.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array